Evolus Inc (EOLS)

Jul 06, 2026

(EOLS) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Jul 06, 2026

Jul 01, 2026

Evolus (EOLS) price target decreased by 11.11% to 14.96 - MSN

Jul 01, 2026

Jun 26, 2026

Evolus Q1 2026 earnings preview - MSN

Jun 26, 2026

Jun 26, 2026

Price to sales forward of Evolus, Inc. Common Stock – NASDAQ:EOLS - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Evolus, Inc. Common Stock – NASDAQ:EOLS - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of Evolus, Inc. Common Stock – NASDAQ:EOLS - TradingView

Jun 26, 2026

Jun 25, 2026

Evolus, Inc. Actuals & Estimates (NASDAQ:EOLS) - TradingView

Jun 25, 2026

Jun 25, 2026

EVL Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

EOLS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

EOLS News | EVOLUS INC (NASDAQ:EOLS) - ChartMill

Jun 24, 2026

Jun 24, 2026

Evolus Inc (EOLS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026

Jun 21, 2026

Evolus, Inc.(NasdaqGM: EOLS) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com

Jun 21, 2026

Jun 20, 2026

Is Evolus (EOLS) Finally Turning the Corner on Profitability - Kavout | AI

Jun 20, 2026

Jun 18, 2026

Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 18, 2026

Evolus Inc (EOLS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026

Jun 17, 2026

Evolus Inc (EOLS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Evolus Inc (EOLS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Evolus Inc (EOLS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Evolus Inc (EOLS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Evolus Inc (EOLS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Evolus Inc (EOLS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Jun 17, 2026

Jun 17, 2026

EOLS Reiterated by BTIG -- Price Target Maintained at $13.00 - GuruFocus

Jun 17, 2026

Jun 15, 2026

[EFFECT] Evolus, Inc. SEC Filing - Stock Titan

Jun 15, 2026

Jun 14, 2026

Understanding the Setup: (EOLS) and Scalable Risk - Stock Traders Daily

Jun 14, 2026

Jun 13, 2026

Evolus shareholders re-elect directors and approve executive compensation By Investing.com - Investing.com South Africa

Jun 13, 2026

Jun 12, 2026

Evolus shareholders re-elect directors and approve executive compensation - Investing.com

Jun 12, 2026

Jun 12, 2026

Evolus (EOLS) shareholders approve directors, auditor and say-on-pay at 2026 meeting - Stock Titan

Jun 12, 2026

Jun 11, 2026

Evolus, Inc. (EOLS) reports Q1 loss, tops revenue estimates - MSN

Jun 11, 2026

Jun 08, 2026

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Jun 08, 2026

Jun 05, 2026

Evolus (NASDAQ: EOLS) registers $250M shelf; $195.5M unsold re‑registered - Stock Titan

Jun 05, 2026

Jun 04, 2026

EOLS: Virtual Meeting with Management Scheduled on June 11 - GuruFocus

Jun 04, 2026

Jun 04, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - GlobeNewswire Inc.

Jun 04, 2026

Jun 04, 2026

Evolus (EOLS) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Jun 04, 2026

Jun 03, 2026

The Technical Signals Behind (EOLS) That Institutions Follow - Stock Traders Daily

Jun 03, 2026

Jun 03, 2026

Evolus (EOLS) Q2 2025 Earnings Call Transcript - AOL.com

Jun 03, 2026

Jun 02, 2026

Evolus Shareholder Notice - TMX Newsfile

Jun 02, 2026

Jun 02, 2026

Evolus Update - TMX Newsfile

Jun 02, 2026

Jun 02, 2026

Evolus Class Action Reminder - TMX Newsfile

Jun 02, 2026

Jun 02, 2026

Evolus Shareholder Alert - TMX Newsfile

Jun 02, 2026

May 28, 2026

Earnings call transcript: Evolus Inc Q1 2026 misses EPS forecast, stock rises - Investing.com Nigeria

May 28, 2026

May 27, 2026

EOLSEvolus Inc Stock Price and Quote - Finviz

May 27, 2026

May 23, 2026

Precision Trading with Evolus Inc. (EOLS) Risk Zones - Stock Traders Daily

May 23, 2026

May 19, 2026

Evolus to Participate in The Jefferies Global Healthcare Conference - Business Wire

May 19, 2026

May 16, 2026

Evolus To Roll Out Estyme Injectable Hyaluronic Acid Fillers in Europe - The Dermatology Digest

May 16, 2026

May 15, 2026

TradingKey - TradingKey

May 15, 2026

May 14, 2026

Evolus Completes Key NUCEIVA Safety Study, Easing Risk for Aesthetic Toxin Investors - TipRanks

May 14, 2026

May 11, 2026

Evolus (EOLS) to Launch Estyme Injectable Collection in Europe - GuruFocus

May 11, 2026

May 11, 2026

Evolus to launch Estyme dermal filler line in Europe on May 16 - Investing.com UK

May 11, 2026

May 11, 2026

Evolus to Launch Estyme Dermal Fillers in Europe - Orange County Business Journal

May 11, 2026

May 11, 2026

Evolus to launch Estyme dermal filler line in Europe on May 16 By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe - marketscreener.com

May 11, 2026